| Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2 N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ... Viruses 12 (6), 582, 2020 | 423 | 2020 |
| Diagnostic efficiency of three fully automated serology assays and their correlation with a novel surrogate virus neutralization test in symptomatic and asymptomatic SARS-COV-2 … S Younes, H Al-Jighefee, F Shurrab, DW Al-Sadeq, N Younes, ... Microorganisms 9 (2), 245, 2021 | 35 | 2021 |
| Evaluation of antibody response in symptomatic and asymptomatic COVID-19 patients and diagnostic assessment of new IgM/IgG ELISA kits HT Al-Jighefee, HM Yassine, MA Al-Nesf, AA Hssain, S Taleb, ... Pathogens 10 (2), 161, 2021 | 34 | 2021 |
| Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies HM Yassine, H Al-Jighefee, DW Al-Sadeq, SR Dargham, SN Younes, ... International journal of infectious diseases 102, 181-187, 2021 | 32 | 2021 |
| COVID-19 vaccine platforms: challenges and safety contemplations HT Al-Jighefee, H Najjar, MN Ahmed, A Qush, S Awwad, L Kamareddine Vaccines 9 (10), 1196, 2021 | 28 | 2021 |
| Organ-specific toxicity evaluation of stearamidopropyl dimethylamine (SAPDMA) surfactant using zebrafish embryos O Al-Jamal, H Al-Jighefee, N Younes, R Abdin, MA Al-Asmakh, ... Science of The Total Environment 741, 140450, 2020 | 21 | 2020 |
| Analytic comparison between three high-throughput commercial SARS-CoV-2 antibody assays reveals minor discrepancies in a high-incidence population GK Nasrallah, SR Dargham, F Shurrab, DW Al-Sadeq, H Al-Jighefee, ... Scientific reports 11 (1), 11837, 2021 | 18 | 2021 |
| Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses. 2020; 12 (6): 582 N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ... | 18 | |
| Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies HT Zedan, HM Yassine, DW Al-Sadeq, N Liu, H Qotba, E Nicolai, M Pieri, ... Scientific reports 12 (1), 19020, 2022 | 15 | 2022 |
| Challenges in laboratory diagnosis of the novel coronavirus SARS-CoV-2. Viruses 2020; 12: 582 N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ... Р, 0 | 15 | |
| Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France HT Zedan, GK Nasrallah EBioMedicine 71, 2021 | 11 | 2021 |
| Can commercial automated immunoassays be utilized to predict neutralizing antibodies after SARS-CoV-2 infection? A comparative study between three different assays. A Ismail, FM Shurrab, HT Al-Jighefee, DW Al-Sadeq, H Qotba, IA Al-Shaar, ... IMR, 2021 | 11 | 2021 |
| Are commercial antibody assays substantially underestimating SARS-CoV-2 ever infection? An analysis on a population-based sample in a high exposure setting GK Nasrallah, SR Dargham, F Shurrab, DW Al-Sadeq, H Al-Jighefee, ... medRxiv, 2020.12. 14.20248163, 2020 | 7 | 2020 |
| Validation of a novel fluorescent lateral flow assay for rapid qualitative and quantitative assessment of total anti-SARS-CoV-2 S-RBD binding antibody units (BAU) from plasma … N Younes, DW Al-Sadeq, FM Shurrab, HT Zedan, H Abou-Saleh, ... Vaccines 10 (8), 1318, 2022 | 6 | 2022 |
| Effect of multiple freeze–thaw cycles on the detection of anti-SARS-CoV-2 IgG antibodies FM Shurrab, DW Al-Sadeq, F Amanullah, SN Younes, H Al-Jighefee, ... Journal of Medical Microbiology 70 (8), 001402, 2021 | 6 | 2021 |
| Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses 2020; 12 N Younes, DW Al-Sadeq, H Al-Jighefee, S Younes, O Al-Jamal, HI Daas, ... | 6 | 2020 |
| Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants HA Al-Khatib, MK Smatti, FH Ali, HT Zedan, S Thomas, MN Ahmed, ... Iscience 25 (11), 2022 | 5 | 2022 |
| COVID-19 Vaccination: The mainspring of challenges and the seed of remonstrance H Najjar, HT Al-Jighefee, A Qush, MN Ahmed, S Awwad, L Kamareddine Vaccines 9 (12), 1474, 2021 | 5 | 2021 |
| Human herpes simplex virus-6 (HHV-6) detection and seroprevalence among Qatari nationals and immigrants residing in Qatar DW Al-Sadeq, HT Zedan, N Aldewik, A Elkhider, A Hicazi, N Younes, ... IJID regions 2, 90-95, 2022 | 4 | 2022 |
| Epidemiology of SARS-CoV2 in Qatar’s primary care population aged 10 years and above MA Syed, AS Al Nuaimi, HA A/Qotba, GK Nasrallah, AA Althani, ... BMC infectious diseases 21, 1-11, 2021 | 4 | 2021 |
